Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

George C. Tsokos, M.D.


This page shows the publications co-authored by George Tsokos and Abhigyan Satyam.
Connection Strength

  1. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol. 2021 05; 226:108716.
    View in: PubMed
    Score: 0.961
  2. Curb complement to cure COVID-19. Clin Immunol. 2020 12; 221:108603.
    View in: PubMed
    Score: 0.930
  3. Cell derived extracellular matrix-rich biomimetic substrate supports podocyte proliferation, differentiation and maintenance of native phenotype. Adv Funct Mater. 2020 Oct 28; 30(44).
    View in: PubMed
    Score: 0.891
  4. Complement Deposition on the Surface of RBC After Trauma Serves a Biomarker of Moderate Trauma Severity: A Prospective Study. Shock. 2020 01; 53(1):16-23.
    View in: PubMed
    Score: 0.883
  5. Complement and coagulation cascades in trauma. Acute Med Surg. 2019 Oct; 6(4):329-335.
    View in: PubMed
    Score: 0.842
  6. Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia. J Immunol. 2017 01 15; 198(2):788-797.
    View in: PubMed
    Score: 0.713
  7. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol. 2021 08; 229:108795.
    View in: PubMed
    Score: 0.245
  8. C3a Enhances the Formation of Intestinal Organoids through C3aR1. Front Immunol. 2017; 8:1046.
    View in: PubMed
    Score: 0.188
  9. A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. Cell Rep Med. 2020 Nov 17; 1(8):100137.
    View in: PubMed
    Score: 0.058
  10. A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic. bioRxiv. 2020 Jun 30.
    View in: PubMed
    Score: 0.057
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.